These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30679762)

  • 1. Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer.
    Murtola TJ; Sälli SM; Talala K; Taari K; Tammela TLJ; Auvinen A
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):453-460. PubMed ID: 30679762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Murtola TJ; Vihervuori VJ; Lahtela J; Talala K; Taari K; Tammela TL; Auvinen A
    Br J Cancer; 2018 May; 118(9):1248-1254. PubMed ID: 29563633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor features and survival after radical prostatectomy among antidiabetic drug users.
    Joentausta RM; Kujala PM; Visakorpi T; Tammela TL; Murtola TJ
    Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):367-373. PubMed ID: 27502739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol and the risk of prostate cancer in a Finnish population-based cohort.
    Kukko V; Kaipia A; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):483-490. PubMed ID: 30696944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic Drugs and Prostate Cancer Prognosis in a Finnish Population-Based Cohort.
    Vihervuori VJ; Talala K; Taari K; Lahtela J; Tammela TLJ; Auvinen A; Raittinen P; Murtola TJ
    Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):982-989. PubMed ID: 33653815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of prostate cancer screening among men using antidiabetic medication.
    Vettenranta A; Murtola TJ; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
    Sci Rep; 2021 Apr; 11(1):7363. PubMed ID: 33795720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer.
    Murtola TJ; Kasurinen TVJ; Talala K; Taari K; Tammela TLJ; Auvinen A
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):66-76. PubMed ID: 30214034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial.
    Neupane S; Steyerberg E; Raitanen J; Talala K; Pylväläinen J; Taari K; Tammela TL; Auvinen A
    Int J Urol; 2018 Mar; 25(3):270-276. PubMed ID: 29224236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
    Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
    BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial.
    Godtman RA; Holmberg E; Khatami A; Stranne J; Hugosson J
    Eur Urol; 2013 Jan; 63(1):101-7. PubMed ID: 22980443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.
    Assel M; Dahlin A; Ulmert D; Bergh A; Stattin P; Lilja H; Vickers AJ
    Eur Urol; 2018 Jun; 73(6):961-967. PubMed ID: 29066048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
    Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
    Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer.
    Ola IO; Talala K; Tammela T; Taari K; Murtola T; Kujala P; Raitanen J; Auvinen A
    Int J Cancer; 2023 Feb; 152(4):672-678. PubMed ID: 36056577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia, Classified with Multiple Biomarkers Simultaneously in Men without Diabetes, and Risk of Fatal Prostate Cancer.
    Marrone MT; Selvin E; Barber JR; Platz EA; Joshu CE
    Cancer Prev Res (Phila); 2019 Feb; 12(2):103-112. PubMed ID: 30538098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
    Murtola TJ; Peltomaa AI; Talala K; Määttänen L; Taari K; Tammela TLJ; Auvinen A
    Eur Urol Focus; 2017 Apr; 3(2-3):212-220. PubMed ID: 28753762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
    Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.
    Macleod LC; Chery LJ; Hu EY; Zeliadt SB; Holt SK; Lin DW; Porter MP; Gore JL; Wright JL
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):190-5. PubMed ID: 25823651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial.
    Godtman RA; Holmberg E; Khatami A; Pihl CG; Stranne J; Hugosson J
    Eur Urol; 2016 Nov; 70(5):760-766. PubMed ID: 27090975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer.
    Wright JL; Plymate SR; Porter MP; Gore JL; Lin DW; Hu E; Zeliadt SB
    Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):204-8. PubMed ID: 23459096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.